9999999997-16-027987.txt : 20161222 9999999997-16-027987.hdr.sgml : 20161222 20161222110701 ACCESSION NUMBER: 9999999997-16-027987 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161222 DATE AS OF CHANGE: 20161222 20161221 20161222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 162065491 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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end